Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 6, 2011, Pages 666-671

  Mowry, Ellen M ^a   James, Judith A ^b   Krupp, Lauren B ^c   Waubant, Emmanuelle ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

cytomegalovirus; Epstein Barr virus infections; herpes simplex; multiple sclerosis; risk factors; vitamin D

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIBODY; VITAMIN D;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PEDIATRICS;

EID: 79959405311     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458510394398     Document Type: Article

References (13)

1. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838 (Pubitemid 44969183)
2. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006 ; 15: 2813-2824 (Pubitemid 44400408)
3. Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epi. 2001 ; 154: 69-74 (Pubitemid 32565688)
4. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005 ; 293: 2496-2500 (Pubitemid 40705731)
5. DiPauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler. 2008 ; 14: 1026-1030
6. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008 ; 70: 66-69 (Pubitemid 350167496)
7. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010 ; 14: e11088 - e11088
8. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One. 2010 ; 5: e8770 - e8770
9. Lunemann JD, Tintore M, Messmer B, et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol. 2010 ; 67: 159-169
10. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001 ; 44: 1122-1126 (Pubitemid 32433618)
11. Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with subsequent relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010 ; 67: 618-624
12. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 ; 5: e1000369 - e1000369
13. Farrell RA, Antony D, Wall GR, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology. 2009 ; 73: 32-38